Global Custom
Recombinant Protein Production Services Market, by Expression System (Mammalian, Bacteria, Insect, Yeast, and
Others), by End User (Research Institutes, Biotechnology and Pharmaceutical
Companies, Contract Research Organizations, and Others), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is
estimated to be valued at US$ 3,575.3 million in 2020 and is projected to
exhibit a CAGR of 11.2% over the forecast period (2020 – 2027), as highlighted
in a new report published by Coherent Market Insights.
Global Custom Recombinant Protein
Production Services Market - Impact of Coronavirus (COVID-19) Pandemic
Following the COVID-19 outbreak
in December 2019, the virus has spread to more than 100 countries across the
globe and the World Health Organization has declared it a public health
emergency. According to the World Health Organization’s report, the
manifestation of coronavirus disease (COVID-19) has resulted in more than 29.6
million infected individuals worldwide as of September 2020. The COVID-19
pandemic has affected the global economy in three main ways; by directly
affecting production and demand, by negatively impacting the supply chain and
market disruption, and through its financial impact on firms and financial
markets. Nationwide lockdowns in various countries such as Italy, Spain, U.K.,
the U.S., Australia, India, and others have disrupted daily life and
activities.
Moreover, severe economic crisis
and broken supply chain (due to Covid 19 lockdown) of bioprocessing industry is
a major issue faced by bioprocessing companies in every country across the
globe. The pandemic has negatively impacted the bioprocessing industry in terms
of supply and demand of biologics. As a result, the global recombinant protein
production services market growth is also expected to witness a slowdown.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2737
The slowdown of pharma,
biopharma, and biotech companies’ manufacturing processes have also impacted
demand for recombinant protein production services.
Browse 37 Market Data Tables and
29 Figures spread through 190 Pages and in-depth TOC on ‘Custom Recombinant
Protein Production Services Market’- Global Forecast to 2027, by Expression
System (Mammalian, Bacteria, Insect, Yeast, and Others), by End User (Research
Institutes, Biotechnology and Pharmaceutical Companies, Contract Research
Organizations, and Others), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa)
The market players are focused on
launching facilities to increase production capacity and expand their offerings
and services, which is expected to boost the market growth. For instance, in
February 2018, Lakepharma, Inc. established a new facility in Massachusetts to
offer fully integrated contract development and manufacturing organization
(CDMO) services, thereby providing end-to-end services to partners and clients.
Similarly, in February 2018, Lakepharma, Inc. launched LakePharma
MicroBiomanufacturing Center in Hopkinton, Massachusetts to enhance its ability
to offer product development and manufacturing.
Moreover, increasing expenditure
on research and development is expected to boost the market growth. For
instance, according to the National Bureau of Statistics, February 2018, China’s expenditure on research and
development increased by 11.6% in 2017 from 10.6% in 2016 reaching to US$ 280
Bn in 2017.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/custom-recombinant-protein-production-services-market-2737
Furthermore, key players in the
market are focused on adopting strategies such as collaborations and
acquisitions to enhance their service offerings. For instance, in 2017,
Eurofins acquired Villapharma Research SL based in Spain to expand its
portfolio of services into comprehensive offering and further strengthen its
service proposition for the pharmaceutical and biotech industries.
Key Takeaways of the Custom
Recombinant Protein Production Services Market:
The global custom recombinant
protein production services market is expected to exhibit a CAGR of 11.2% over
the forecast period. This is owing to advancements in bioreactor systems that
have reduced production time for recombinant proteins.
Among expression systems, the
mammalian segment is estimated to hold dominant position in the custom
recombinant protein production services market in 2020. This is owing to the
ability of mammalian expression to offer optimized transient system for rapid
yield of protein production.
Among end users, biotechnology
and pharmaceutical companies segment is estimated to hold dominant position in
the custom recombinant protein production services market in 2020, owing to
increasing number of research and development activities. According to
Pharmaceutical Research and Manufacturers of America (PhRMA), 2016, member
companies invested an estimated US$ 58.8 billion in research and development in
2015, which was the majority of all biopharmaceutical R&D spending in the
U.S.
Key players operating in the
global custom recombinant protein production services market include GenScript
Biotech Corporation, Applied Biological Materials Inc., Eurofins Pharma
Discovery Services, Abgent, OriGene Technologies, Inc., Crown Bioscience, Inc.,
BPS Bioscience, Inc., ProteoGenix, Kempbio, Inc., Novoprotein, Premas Biotech,
Trenzyme GmbH, Atum, Novus Biologicals, LLC, Icosagen AS, LakePharma, Inc.,
Proteos, Inc., Aldevron, Sino Biological Inc., and SignalChem Lifesciences
Corporation
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2737
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging market
trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
